Is alt a good short term buy

**Altimmune's stock does not appear to be a strong short-term buy**. Here's the analysis to support this conclusion:

1. **Recent Stock Performance**: Altimmune's stock has experienced a decline, with a 1-month interval percentage change of -8.13% and a 1-year percentage change of -44.79%. This indicates a recent trend of the stock price going down.

|Ticker|Name|Date|Interval Percentage Change|code|market_code|
|---|---|---|---|---|---|
|ALT.O|Altimmune|20240709-20240808|-8.127721335268498|ALT|185|
|ALT.O|Altimmune|20240801-20240808|-0.47169811320755106|ALT|185|

2. **Technical Indicators**: The 5-day moving average is $5.91, and the 10-day moving average is $6.16. The fact that the short-term moving average is below the longer-term moving average can suggest a bearish trend.

3. **Short Interest**: The short interest in Altimmune is substantial, with over 30% of shares shorted. This indicates a negative sentiment among short sellers, which could be a bearish signal.
4. **Forecast Price**: The forecast price for Altimmune stock in the next ten trading days ranges from $5.86 to $6.44. These prices are below the current closing price of $6.33, suggesting that the forecast sees a potential decline.

|Ticker|Name|Date|Forecast Price|code|market_code|
|---|---|---|---|---|---|
|ALT.O|Altimmune|20240809|6.4170078|ALT|185|
|ALT.O|Altimmune|20240812|6.32597356|ALT|185|
|ALT.O|Altimmune|20240813|6.44112239|ALT|185|
|ALT.O|Altimmune|20240814|6.37776921|ALT|185|
|ALT.O|Altimmune|20240815|6.26058107|ALT|185|
|ALT.O|Altimmune|20240816|6.23429756|ALT|185|
|ALT.O|Altimmune|20240819|6.03522683|ALT|185|
|ALT.O|Altimmune|20240820|5.89670591|ALT|185|
|ALT.O|Altimmune|20240821|5.88695348|ALT|185|
|ALT.O|Altimmune|20240822|5.86489809|ALT|185|

5. **Analyst Ratings**: Despite the negative sentiment, analysts have set an average 12-month price target of $20.25, with a high of $25.00 and a low of $12.00. This suggests that analysts see potential for growth in the long term.

In conclusion, while analysts have set a high price target that could indicate potential for growth, the current technical indicators and short-term forecast suggest that Altimmune's stock may not be a good short-term buy. Investors should consider the potential for short-term price declines and focus on the long-term growth prospects.